Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

The histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet k...

Full description

Bibliographic Details
Main Authors: Bowers, E, Yan, G, Mukherjee, C, Orry, A, Wang, L, Holbert, M, Crump, N, Hazzalin, C, Liszczak, G, Yuan, H, Larocca, C, Saldanha, SA, Abagyan, R, Sun, Y, Meyers, D, Marmorstein, R, Mahadevan, L, Alani, R, Cole, P
Format: Journal article
Language:English
Published: 2010
_version_ 1797103689966551040
author Bowers, E
Yan, G
Mukherjee, C
Orry, A
Wang, L
Holbert, M
Crump, N
Hazzalin, C
Liszczak, G
Yuan, H
Larocca, C
Saldanha, SA
Abagyan, R
Sun, Y
Meyers, D
Marmorstein, R
Mahadevan, L
Alani, R
Cole, P
author_facet Bowers, E
Yan, G
Mukherjee, C
Orry, A
Wang, L
Holbert, M
Crump, N
Hazzalin, C
Liszczak, G
Yuan, H
Larocca, C
Saldanha, SA
Abagyan, R
Sun, Y
Meyers, D
Marmorstein, R
Mahadevan, L
Alani, R
Cole, P
author_sort Bowers, E
collection OXFORD
description The histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet known. Here we use a structure-based, in silico screening approach to identify a commercially available pyrazolone-containing small molecule p300 HAT inhibitor, C646. C646 is a competitive p300 inhibitor with a K(i) of 400 nM and is selective versus other acetyltransferases. Studies on site-directed p300 HAT mutants and synthetic modifications of C646 confirm the importance of predicted interactions in conferring potency. Inhibition of histone acetylation and cell growth by C646 in cells validate its utility as a pharmacologic probe and suggest that p300/CBP HAT is a worthy anticancer target.
first_indexed 2024-03-07T06:23:41Z
format Journal article
id oxford-uuid:f388caf1-a708-46d0-b8b7-937d5f6b6b86
institution University of Oxford
language English
last_indexed 2024-03-07T06:23:41Z
publishDate 2010
record_format dspace
spelling oxford-uuid:f388caf1-a708-46d0-b8b7-937d5f6b6b862022-03-27T12:12:56ZVirtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f388caf1-a708-46d0-b8b7-937d5f6b6b86EnglishSymplectic Elements at Oxford2010Bowers, EYan, GMukherjee, COrry, AWang, LHolbert, MCrump, NHazzalin, CLiszczak, GYuan, HLarocca, CSaldanha, SAAbagyan, RSun, YMeyers, DMarmorstein, RMahadevan, LAlani, RCole, PThe histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet known. Here we use a structure-based, in silico screening approach to identify a commercially available pyrazolone-containing small molecule p300 HAT inhibitor, C646. C646 is a competitive p300 inhibitor with a K(i) of 400 nM and is selective versus other acetyltransferases. Studies on site-directed p300 HAT mutants and synthetic modifications of C646 confirm the importance of predicted interactions in conferring potency. Inhibition of histone acetylation and cell growth by C646 in cells validate its utility as a pharmacologic probe and suggest that p300/CBP HAT is a worthy anticancer target.
spellingShingle Bowers, E
Yan, G
Mukherjee, C
Orry, A
Wang, L
Holbert, M
Crump, N
Hazzalin, C
Liszczak, G
Yuan, H
Larocca, C
Saldanha, SA
Abagyan, R
Sun, Y
Meyers, D
Marmorstein, R
Mahadevan, L
Alani, R
Cole, P
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title_full Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title_fullStr Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title_full_unstemmed Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title_short Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
title_sort virtual ligand screening of the p300 cbp histone acetyltransferase identification of a selective small molecule inhibitor
work_keys_str_mv AT bowerse virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT yang virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT mukherjeec virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT orrya virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT wangl virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT holbertm virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT crumpn virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT hazzalinc virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT liszczakg virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT yuanh virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT laroccac virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT saldanhasa virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT abagyanr virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT suny virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT meyersd virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT marmorsteinr virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT mahadevanl virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT alanir virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor
AT colep virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor